Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03636542 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Diaphragm Movement After an Interscalene Block
A Phase 4 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT03636542 is a Phase 4 study that has completed, run by University of Minnesota. The registered enrollment target is 26 participants.
The verdict
NCT03636542, a Phase 4 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the movement of the diaphragm after an interscalene block with liposome bupivacaine (LB) compared to interscalene block (IB) with bupivacaine. This study will evaluate if there is a possible prolonged phrenic nerve paralysis when using liposome bupivacaine in an interscalene block, using ultrasound.
Interventions
- DRUG bupivacaine
- DRUG liposomal bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2020-06-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03636542
The ClinicalTrials.gov registry entry for NCT03636542 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which bupivacaine is the first listed.
NCT03636542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03636542 about?
NCT03636542 is a clinical study titled "Evaluation of Diaphragm Movement After an Interscalene Block". The purpose of this study is to evaluate the movement of the diaphragm after an interscalene block with liposome bupivacaine (LB) compared to interscalene block (IB) with bupivacaine. This study will evaluate if there is a possible prolonged phrenic nerve paralysis when using liposome bupivacaine in...
What is the current status of trial NCT03636542?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2018-08-01. Estimated completion is 2020-06-03.
What interventions are being tested in trial NCT03636542?
The interventions under investigation include: bupivacaine (DRUG), liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03636542?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.